HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atieh Pourbagheri-Sigaroodi Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

6/2021The contributory role of long non-coding RNAs (lncRNAs) in head and neck cancers: Possible biomarkers and therapeutic targets?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atieh Pourbagheri-Sigaroodi Research Topics

Disease

25Neoplasms (Cancer)
04/2024 - 01/2018
7Acute Promyelocytic Leukemia
04/2023 - 12/2018
5COVID-19
01/2022 - 11/2020
4Leukemia
11/2021 - 10/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2022 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2021
2Breast Neoplasms (Breast Cancer)
12/2021 - 01/2018
2Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 03/2019
2Multiple Myeloma
11/2021 - 01/2019
2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
05/2020 - 10/2018
1Lung Neoplasms (Lung Cancer)
04/2024
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2024
1Neoplasm Metastasis (Metastasis)
12/2023
1Melanoma (Melanoma, Malignant)
01/2022
1Acute Lung Injury
01/2022
1Lymphoma (Lymphomas)
11/2021
1Neuroinflammatory Diseases
11/2021
1Virus Diseases (Viral Diseases)
08/2021
1Lung Injury
08/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2021
1Carcinogenesis
01/2021
1Squamous Cell Carcinoma of Head and Neck
01/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Inflammation (Inflammations)
01/2020

Drug/Important Bio-Agent (IBA)

7Arsenic Trioxide (Trisenox)FDA Link
04/2023 - 01/2018
4Phosphatidylinositols (Phosphatidylinositol)IBA
11/2023 - 12/2018
3NVP-BKM120IBA
01/2020 - 12/2018
2Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2021
2Immune Checkpoint InhibitorsIBA
12/2021 - 10/2021
2MicroRNAs (MicroRNA)IBA
12/2021 - 03/2019
2EnzymesIBA
11/2021 - 05/2020
2Histone Deacetylase InhibitorsIBA
11/2021 - 05/2020
2Histone Deacetylases (Histone Deacetylase)IBA
11/2021 - 05/2020
2Biomarkers (Surrogate Marker)IBA
06/2021 - 11/2020
2Toll-Like Receptor 4IBA
01/2021 - 01/2020
2Pioglitazone (Actos)FDA Link
01/2021 - 01/2020
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021 - 01/2021
1Cancer VaccinesIBA
04/2024
1VaccinesIBA
04/2024
1Inosine Triphosphate (ITP)IBA
02/2024
1Peptide Hydrolases (Proteases)FDA Link
12/2023
1MTOR InhibitorsIBA
11/2023
1TOR Serine-Threonine KinasesIBA
11/2023
1idelalisibIBA
04/2023
1Protein Isoforms (Isoforms)IBA
04/2023
1Daunorubicin (Cerubidine)FDA LinkGeneric
07/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
07/2022
1AnthracyclinesIBA
07/2022
1Dual-Specificity PhosphatasesIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022
1Insulin (Novolin)FDA Link
11/2021
1CytokinesIBA
06/2021
1Antiviral Agents (Antivirals)IBA
06/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Toll-Like Receptor AgonistsIBA
01/2021
1AutoantigensIBA
01/2021
1Trypan BlueFDA Link
01/2021
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2021
1PPAR gammaIBA
01/2021
1PanobinostatIBA
05/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
01/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2019
1BIBR 1532IBA
03/2019
1carfilzomibIBA
01/2019
1Aprepitant (Emend)FDA Link
10/2018
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
10/2018
1Hormones (Hormone)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1MelatoninIBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1SurvivinIBA
01/2018

Therapy/Procedure

18Therapeutics
12/2023 - 01/2018
5Immunotherapy
02/2022 - 01/2021
2Drug Therapy (Chemotherapy)
01/2022 - 12/2018
1Molecular Targeted Therapy
01/2022
1Immunomodulation
08/2021
1Radiotherapy
01/2021